opc 21268 has been researched along with Kidney Failure, Chronic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanno, Y; Okada, H; Saruta, T; Suzuki, H; Yamamura, Y | 1 |
Miura, Y; Nakano, H; Nakayama, M; Suzuki, S; Tuchida, H; Yamada, K; Yoshida, S | 1 |
Miura, Y; Nakano, H; Nakayama, M; Suzuki, S; Tsuchida, H; Yamada, K; Yoshida, S | 1 |
3 other study(ies) available for opc 21268 and Kidney Failure, Chronic
Article | Year |
---|---|
Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Kidney; Kidney Failure, Chronic; Male; Piperidines; Quinolones; Rats; Rats, Wistar; Urine | 1994 |
A lack of anti-hypertensive effect of an orally effective V1 receptor antagonist, OPC-21268, in end-stage renal disease.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Middle Aged; Piperidines; Quinolones | 1993 |
The effect of OPC-21268, an oral, nonpeptide arginine vasopressin V1 receptor antagonist, on a patient with congestive heart failure.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Diabetes Mellitus, Type 2; Female; Heart Failure; Heart Rate; Humans; Kidney Failure, Chronic; Piperidines; Quinolones | 1993 |